We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Global Medical Robotics Market to Reach USD 20 Billion by 2022

By HospiMedica International staff writers
Posted on 20 Sep 2017
The global medical robotics market is expected to grow at a CAGR of 21.6%from USD 6.36 billion in 2016 to USD 20.56 billion by 2022, driven by the enhancement of automation technologies, rising incidence of disabilities in human beings and growing baby boomer population, that impede their day-to-day physical motions.

These are the latest findings of Research and Markets (Dublin, Ireland), a global market research company.
Medical robots are used by surgeons to gain greater access to areas under operation using more detailed and less invasive methods. More...
They are present in most telemanipulators, which use the surgeon's actions on one side and to control the "effector" on the other side.

Currently, the demand for medical robots is driven by the rapidly growing demand for precise and efficient minimally invasive surgeries, although the high cost of surgery, negative publicity, and wariness among people continue to pose a challenge to the market growth. The neurology segment is expected to register the fastest growth in the medical robots market during the forecast period, driven by the advent of newer applications in neurosurgery and the growing popularity of robotic neurosurgery.

In 2016, North America held the highest share of the global medical robotics market, due to the high adoption rate of medical robots in the region and the government's strong focus on medical robots to improve the quality of healthcare. The medical robotic systems market in Asia Pacific is expected to grow at the fastest rate during the forecast period due to the availability of untapped market opportunities.

Related Links:
Research and Markets


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.